1. Cost-Effectiveness of Routine Screening for Cardiac Toxicity in Patients Treated with Imatinib in Brazil 
Eduardo Gehling Bertoldi, MD, MSc, Milena S. Marcolino, MD, ScD, Luis Eduardo P. Rohde, MD, ScD, Antonio Luiz Ribeiro, MD, ScD, Carisi A. Polanczyk, MD, ScD 
Value in Health Regional Issues 
Volume 1, Issue 2, Pages (December 2012)
DOI: /j.vhri
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Decision tree representing the evaluated screening strategies. BNP, B-type natriuretic peptide; CML, chronic myeloid leukemia; echo, echocardiogram.
Value in Health Regional Issues 2012 1, DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions